17:23

CALQUENCE® (acalabrutinib) Pooled Safety Analysis – Dr Pinilla-lbarz, MD

15:59

CALQUENCE® (acalabrutinib) Long-Term Data – Dr Brem, MD

31:15

CALQUENCE® (acalabrutinib) Clinical Insights from a Real-World Patient with Treatment Naive CLL

22:04

CALQUENCE® (acalabrutinib) ELEVATE-TN, Including 6-Year Median Follow-Up Data – Dr O’ Brien, MD

18:35

CALQUENCE® (acalabrutinib) ACE-CL-001 (ibrutinib-intolerant cohort) – Dr Raval, MD

16:42

CALQUENCE® (acalabrutinib) Patient Management & Adherence – Bradley, NP

1:08:05

A Patient Story

20:01

CALQUENCE® (acalabrutinib) MAIC of ASCEND and ALPINE – Dr Skarbnik, MD